Celmatix
Celmatix Partners With Onctotest-Teva to Offer Reproductive Health Genetic Test in Israel
The Fertilome test, a multigene sequencing panel, assesses a number of markers that have been associated with conditions that affect fertility.
The firm recently won $4.5 million as well as approval for its Fertilome test from New York state, though some have questioned the test's clinical utility.
Celmatix Wins $4.5M From New York State to Expand NYC Headquarters
The award is one of 121 for projects in New York City this year, totaling $64.8 million.
Celmatix Receives NY State Approval for Reproductive Health Gene Panel
The firm has secured NYS approval for its sequencing-based 32-gene Fertilome assay, which it originally launched in January.Â
A microfluidic phone attachment developed at Brigham and Women's and Mass General may be the precursor of a fertility assay that men can use in the home. Â
Jan 17, 2017